Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Other Operating Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Operating Expenses for 16 consecutive years, with $11.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 1.21% to $11.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $46.2 million, a 12.36% decrease, with the full-year FY2024 number at $49.2 million, up 1238.79% from a year prior.
  • Other Operating Expenses was $11.7 million for Q3 2025 at Xtant Medical Holdings, up from $11.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $15.2 million in Q4 2023 to a low of -$20.0 million in Q4 2022.
  • A 5-year average of $4.8 million and a median of $5.3 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: tumbled 477.02% in 2022, then surged 659.62% in 2024.
  • Xtant Medical Holdings' Other Operating Expenses stood at $5.3 million in 2021, then crashed by 477.02% to -$20.0 million in 2022, then soared by 176.11% to $15.2 million in 2023, then decreased by 23.36% to $11.7 million in 2024, then rose by 0.53% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Other Operating Expenses are $11.7 million (Q3 2025), $11.6 million (Q2 2025), and $11.2 million (Q1 2025).